论文信息 - Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer (PC) in Japan and Taiwan: GEST study. - 字舞流文

Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer (PC) in Japan and Taiwan: GEST study.

J. Furuse | Y. Ohashi | K. Mizumoto | H. Baba | S. Egawa | K. Sugimori | T. Okusaka | K. Yamao | T. Hatori | T. Ioka | H. Yanagimoto | S. Ohkawa | A. Funakoshi | A. Fukutomi | A. Sato | T. Shimamura | T. Yamaguchi | M. Ikeda | J. Chen | A. Cheng